The clinical management of bladder cancer has seen little change over the last three
decades and there is pressing need to identify more effective treatments for advanced …

Penile cancer is a rare malignancy, particularly in industrialized nations. In the United
States, rates are approximately less than 1 per 100,000 men per year with just over 2000 …

Simple Summary Penile squamous cell carcinoma (PSCC) is a rare and aggressive cancer.
About half of all PSCC cases are thought to be related to human papillomavirus (HPV) or …

It has been shown that human papillomavirus (HPV) and p16 status has prognostic value in
some HPV-associated cancers. However, studies examining survival in men with penile …

Human papillomavirus (HPV), a member of the Papillomaviridae family, is a small (8kb),
nonenveloped, double‐stranded DNA virus. HPV has a predilection for infecting cutaneous …

Penile squamous cell carcinoma (PeSCCA) is a rare malignancy for which there are limited
treatment options due to a poor understanding of the molecular alterations underlying …

BACKGROUND: Penile squamous cell carcinomas (SCC) arise either through transforming
infections with human papillomavirus (HPV) or independent of HPV, often in the background …

Penile squamous cell carcinoma is a rare malignancy with various distinct histological
subtypes, each with distinct appearances, histotypic specific associations with human …

Human papillomavirus (HPV) infection drives tumorigenesis in almost all cervical cancers
and a fraction of vulvar and penile cancers. Due to increasing incidence and low vaccination …

Human papillomavirus (HPV) is associated with cancer of the cervix uteri, penis, vulva,
vagina, anus and oropharynx. However, the role of HPV infection in urological tumors is not …